ALLO Chart
See on advanced chart >
About
Allogene Therapeutics, Inc. was incorporated on November 30, 2017 in the State of Delaware and is headquartered in South San Francisco, California. The company is a clinical stage immuno-oncology company pioneering the development and commercialization of...
Read More
- HighlightA company that developing genetically engineered allogeneic T cell therapies for cancer
- ExchangeNASDAQ
- Listing Date10/11/2018
- Established Date11/30/2017
- Full-time Employees232
- Address210 East Grand Avenue South San Francisco California 94080
- Tel1-650-4572700
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology